Harnessing the Power of Phosphoramidate Chemistry

Unlocking the Potential of Immunotherapy

Our new anti-cancer agents have the potential to change the standards of care for patients across a broad range of cancers

We are a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer. Utilizing our proprietary phosphoramidate technology we are developing more effective and safer anti-cancer medicines.

NuCana is led by a highly experienced management team with extensive drug development & commercialization expertise.